Real-Time European Filings API. Request Access
scPharmaceuticals Inc. Logo

scPharmaceuticals Inc.

Commercializes subcutaneous drug-device therapies for at-home cardiorenal care.

SCPH | US

Overview

Corporate Details

ISIN(s):
US8106481059
LEI:
Country:
United States of America
Address:
25 BURLINGTON MALL ROAD, SUITE 203, 1803 BURLINGTON
Website:
https://www.scpharmaceuticals.com/
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

scPharmaceuticals Inc. is a commercial-stage pharmaceutical company, operating as a subsidiary of MannKind Corporation, focused on developing and commercializing patient-centric treatments for cardiorenal diseases. The company specializes in drug-device combinations that facilitate subcutaneous drug delivery, aiming to improve patient outcomes and shift care from clinical settings to the home. Its flagship product, FUROSCIX®, is a proprietary formulation of furosemide delivered via an auto-injector for treating congestion in patients with heart failure and, as of 2025, chronic kidney disease. The company's strategy centers on creating value-based solutions that reduce the burden of care and enhance quality of life for patients with cardiovascular and renal conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all scPharmaceuticals Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for scPharmaceuticals Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for scPharmaceuticals Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Upstream Bio, Inc. Logo
Upstream Bio, Inc.
Developing a monoclonal antibody for severe inflammatory and respiratory diseases.
United States of America
UPB
UroGen Pharma Ltd. Logo
UroGen Pharma Ltd.
Develops non-surgical therapies for urological cancers using proprietary hydrogel technology.
United States of America
URGN
Valbiotis Logo
Valbiotis
Develops clinically tested, plant-based supplements for metabolic & cardiovascular health.
France
ALVAL
Valneva SE Logo
Valneva SE
Develops and commercializes vaccines for infectious diseases like chikungunya, Lyme, and Zika.
France
VLA
Vanda Pharmaceuticals Inc. Logo
Vanda Pharmaceuticals Inc.
Develops and commercializes innovative therapies for central nervous system disorders.
United States of America
VNDA
Vaxcell-Bio Therapeutics Logo
Vaxcell-Bio Therapeutics
Develops CAR-T and CAR-NK immunotherapies for solid tumors and canine lymphoma.
South Korea
323990
Vaxcyte, Inc. Logo
Vaxcyte, Inc.
A clinical-stage company developing broad-spectrum vaccines for bacterial infectious diseases.
United States of America
PCVX
VENTURE LIFE GROUP PLC Logo
VENTURE LIFE GROUP PLC
Develops, manufactures, and distributes consumer self-care products and medical devices globally.
United Kingdom
VLG
Ventyx Biosciences, Inc. Logo
Ventyx Biosciences, Inc.
Clinical-stage biopharma developing oral therapies for autoimmune, inflammatory & neuro diseases.
United States of America
VTYX
Verastem, Inc. Logo
Verastem, Inc.
Develops cancer medicines targeting the RAS/MAPK pathway, with an approved therapy for ovarian cancer.
United States of America
VSTM

Talk to a Data Expert

Have a question? We'll get back to you promptly.